Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma
Theodore H. Welling, Mary Feng, Shanshan Wan, Sin Ye Hwang, Michael L. Volk, Theodore S. Lawrence, Mark M. Zalupski, Christopher J. Sonnenday – 1 October 2013 – Hilar cholangiocarcinoma (CCA) is a difficult malignancy to treat surgically because of its anatomical location and its frequent association with primary sclerosing cholangitis. Neoadjuvant chemoradiotherapy followed by liver transplantation in lymph node–negative patients has been advanced by select liver transplant centers for the treatment of patients with unresectable disease.